Dec 4 (Reuters) - U.S. drugmaker Novavax NVAX.O said on Wednesday that it has signed an agreement to sell its manufacturing facility in Bohumil, Czech Republic, to Novo Nordisk NOVOb.CO for $200 million.
(Reporting by Gnaneshwar Rajan in Bengaluru)
((Gnaneshwar.Rajan@thomsonreuters.com;))